Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors
- PMID: 16716852
- DOI: 10.1016/j.jsat.2006.03.013
Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors
Abstract
The recent approval of buprenorphine for the treatment of opiate dependence offers an opportunity to analyze innovation adoption in community-based treatment. Using data collected from national samples of 299 privately funded and 277 publicly funded treatment centers, this research examines buprenorphine adoption using baseline data collected between 2002 and 2004 as well as follow-up data collected 12 months later. Private centers were significantly more likely than public centers to report current use of buprenorphine. The baseline data indicated that early adoption was positively associated with center accreditation, physician services, availability of detoxification services, current use of naltrexone, and the percentage of opiate-dependent clients. Multivariate analyses of follow-up data suggest that adoption was greater in accredited centers, for-profit facilities, organizations offering detoxification services, and naltrexone-using centers. Future research should continue to monitor the extent to which buprenorphine is adopted in these settings.
Similar articles
-
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137. Milbank Q. 2015. PMID: 26350930 Free PMC article.
-
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4. Rural Remote Health. 2015. PMID: 25651434 Review.
-
Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.J Subst Abuse Treat. 2012 Jan;42(1):16-24. doi: 10.1016/j.jsat.2011.06.009. Epub 2011 Aug 9. J Subst Abuse Treat. 2012. PMID: 21831565 Free PMC article.
-
Contingency management: utility in the treatment of drug abuse disorders.Clin Pharmacol Ther. 2008 Apr;83(4):644-7. doi: 10.1038/sj.clpt.6100508. Epub 2008 Feb 27. Clin Pharmacol Ther. 2008. PMID: 18305456 Review.
-
Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.Drug Alcohol Depend. 2006 Jul 27;83(3):274-8. doi: 10.1016/j.drugalcdep.2005.12.005. Epub 2006 Jan 18. Drug Alcohol Depend. 2006. PMID: 16413146
Cited by
-
Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics: A Randomized Clinical Trial.JAMA Netw Open. 2022 Oct 3;5(10):e2236904. doi: 10.1001/jamanetworkopen.2022.36904. JAMA Netw Open. 2022. PMID: 36251291 Free PMC article. Clinical Trial.
-
Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.Drug Alcohol Rev. 2020 Nov;39(7):857-861. doi: 10.1111/dar.13058. Epub 2020 Apr 12. Drug Alcohol Rev. 2020. PMID: 32281200 Free PMC article.
-
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics. 2020 Jan;17(1):55-69. doi: 10.1007/s13311-019-00814-4. Neurotherapeutics. 2020. PMID: 31907876 Free PMC article. Review.
-
Patient Characteristics Associated with Receipt of Prescription Weight-Management Medications Among Veterans Participating in MOVE!Obesity (Silver Spring). 2019 Jul;27(7):1168-1176. doi: 10.1002/oby.22503. Epub 2019 May 15. Obesity (Silver Spring). 2019. PMID: 31090207 Free PMC article.
-
Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.J Behav Health Serv Res. 2019 Jan;46(1):151-163. doi: 10.1007/s11414-018-9629-4. J Behav Health Serv Res. 2019. PMID: 30069622 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical